Startup India Government of India
Jambuwala Pharmaceuticals Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹11.41 Cr
▲ 44% YoY
Net profit · FY 2025
₹53.51 Lakh
Net margin 4.7%
EBITDA · FY 2025
₹2.45 Cr
EBITDA margin 21.5%
Authorised capital
₹6.1 Cr
Registered with MCA
Paid-up capital
₹6.09 Cr
Issued & subscribed
Open charges
₹10.6 Cr
Secured borrowings
Company age
9 yrs
Est. 2017
Employees · EPFO
37
Provident fund records
About Jambuwala Pharmaceuticals Limited
Data last updated:
Jambuwala Pharmaceuticals Limited is a public limited company based in Ahmedabad, Gujarat, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 August 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24100GJ2017PLC098725. Its GSTIN is 24AAECJ0547L1ZK (Gujarat).
The company has an authorised share capital of ₹6.1 Cr and a paid-up capital of ₹6.09 Cr. It is led by directors including Pranlal Bhailal Shah and Rasilaben Pranlal Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Park, Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.41 Cr, a growth of 44% compared to the previous year. For the same year it recorded a net profit of ₹53.51 Lakh (net margin 4.7%) and EBITDA of ₹2.45 Cr (EBITDA margin 21.5%). Revenue has grown at a compounded annual rate (CAGR) of 64% over three years and 191% over five years.
The company has about 37 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Jambuwala Commodities. As per MCA filings, the company has open charges of ₹10.6 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jambuwala.com.
Company details
CIN U24100GJ2017PLC098725
Registration Number 098725
Incorporation Date 17 August 2017
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Key People
Pranlal Bhailal Shah Director Rasilaben Pranlal Shah Director Kamal Pranlal Shah Director Recognitions & Rankings of Jambuwala Pharmaceuticals
Contact details
Jambuwala Pharmaceuticals Limited's registered office is in Ahmedabad, Gujarat. Its website is jambuwala.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSubplot C – 19 20 21 22 Gallops Ind. Park2 NH – 8A Ahmd – Rajkot Highway Chachrawadi Vasna S, Anand, Ahmedabad, Gujarat, India – 382213
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Jambuwala Pharmaceuticals Limited, buy the company report.
Comprehensive company report
Jambuwala Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Jambuwala Pharmaceuticals operates one associated brand: Jambuwala Commodities. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides financial trading, investment planning, and sustainable banking services. | jambuwala.com |
Business activity
The main business activity of Jambuwala Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Jambuwala Pharmaceuticals Limited, buy the company report.
Financials of Jambuwala Pharmaceuticals Limited
FY 2025 filings availableJambuwala Pharmaceuticals Limited reported revenue of ₹11.41 Cr (up 44% YoY) for FY 2025.
Revenue · FY 2025
₹11.41 Cr ▲ 44%
Net profit · FY 2025
₹53.51 Lakh margin 4.7%
EBITDA · FY 2025
₹2.45 Cr margin 21.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 44%
3 years · compounded
▲ 64%
5 years · compounded
▲ 191%
EBITDA CAGR growth
1 year
▲ 362%
3 years · compounded
▲ 53%
5 years · compounded
▲ 158%
Revenue has grown at a compounded annual rate (CAGR) of 191% over five years, including 44% growth in the latest year. EBITDA rose 362% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.45 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹53.51 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.5% | ||||
| Net Profit Margin | 4.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jambuwala Pharmaceuticals Limited, buy the company report.
Board of directors of Jambuwala Pharmaceuticals Limited
Jambuwala Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pranlal Bhailal Shah | Director | 17 Aug 2017 | 9 Years 2 Months | Current |
| Rasilaben Pranlal Shah Also directs: Jambuwala Commodities Private Limited, Jambuwala Foundation | Director | 17 Aug 2024 | 2 Years 2 Months | Current |
| Kamal Pranlal Shah Also directs: Jambuwala International Ifsc Private Limited, Jambuwala Commodities Private Limited, Jambuwala Foundation and 1 more | Director | 17 Aug 2017 | 9 Years 2 Months | Current |
Auditor
Jambuwala Pharmaceuticals Limited is audited by B C M ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B C M ASSOCIATES | FY 2024 | 100808W |
Shareholding
The shareholding of Jambuwala Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Jambuwala Pharmaceuticals Limited, buy the company report.
Charges & borrowings
Open charges
₹10.6 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Mar 2019 | 100251220 | Sidbi | ₹10.6 Cr | Open |
To see the full charge records of Jambuwala Pharmaceuticals Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Jambuwala Pharmaceuticals Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jambuwala Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Jambuwala Pharmaceuticals Limited has a workforce of 37 employees on its EPFO records as of Feb 28, 2025, across 1 active EPFO establishment.
Employee count
37
Active EPFO establishments
1
Employee growth
8.82%
GST
Jambuwala Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECJ0547L1ZK | Gujarat | Active | 02 Feb 2018 |
To see the full GST registrations and return filing status of Jambuwala Pharmaceuticals Limited, buy the company report.
Recent activity
Jambuwala Pharmaceuticals Limited has 6 board changes on record since 2017: 3 appointments and 3 cessations. The latest: Rasilaben Pranlal Shah ceased to be Additional Director on 29 Sep 2024.
AGM
Jambuwala Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Jambuwala Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Rasilaben Pranlal Shah ceased to be Additional Director.
Appointed
Rasilaben Pranlal Shah was appointed as Director.
Charges
A charge with Sidbi of Rs. 10.60 Cr registered on 01 Mar 2019 with Charge ID 100251220 was modified on 28 Mar 2024.
Ceased
Chintan Pranlal Shah ceased to be Director.
Ceased
Hiren Vijaykumar Doshi ceased to be Director.
Charges
A charge with Sidbi amounted to Rs. 10.60 Cr with Charge ID 100251220 was registered on 01 Mar 2019.
Appointed
Kamal Pranlal Shah was appointed as Director.
Appointed
Pranlal Bhailal Shah was appointed as Director.
Incorporation
17 Aug 2017
Jambuwala Pharmaceuticals Limited was registered on 17 Aug 2017 with Roc Ahmedabad & aged 9 years 2 months as per MCA records.
Frequently asked questions
Jambuwala Pharmaceuticals is an active public limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 August 2017 (9+ years old) and is registered under CIN U24100GJ2017PLC098725.
Jambuwala Pharmaceuticals has 3 current directors:
- Pranlal Bhailal Shah - Director
- Rasilaben Pranlal Shah - Director
- Kamal Pranlal Shah - Director
The latest financial statements of Jambuwala Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Jambuwala Pharmaceuticals is 24AAECJ0547L1ZK, registered in Gujarat.
The CIN (Corporate Identification Number) of Jambuwala Pharmaceuticals is U24100GJ2017PLC098725. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jambuwala Pharmaceuticals was incorporated on 17 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Rasilaben Pranlal Shah ceased to be Additional Director on 29 Sep 2024. Rasilaben Pranlal Shah was appointed as Director on 17 Aug 2024. Chintan Pranlal Shah ceased to be Director on 23 Aug 2021. Jambuwala Pharmaceuticals has 6 board changes on record in total.
Yes, Jambuwala Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Jambuwala Pharmaceuticals can be reached through the website jambuwala.com. Its registered office is in Ahmedabad, Gujarat, India.
The registered office of Jambuwala Pharmaceuticals is at Subplot C – 19 20 21 22 Gallops Ind. Park2 NH – 8A Ahmd – Rajkot Highway Chachrawadi Vasna S, Anand, Ahmedabad, Gujarat, India – 382213.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages